DE60020444D1 - Melanoma Therapie - Google Patents

Melanoma Therapie

Info

Publication number: DE60020444D1
Authority: DE; Germany
Prior art keywords: melanoma therapy; melanoma; therapy
Prior art date: 1999-04-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60020444T

Other languages

English (en)

Other versions

DE60020444T2 (de

Inventor

Mary Ellen Rybak

Esther Helen Westfield Nj Rose

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Sharp and Dohme LLC

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-08

Filing date

2000-04-06

Publication date

2005-07-07

2000-04-06 Application filed by Schering Corp filed Critical Schering Corp

2005-07-07 Publication of DE60020444D1 publication Critical patent/DE60020444D1/de

2006-05-04 Application granted granted Critical

2006-05-04 Publication of DE60020444T2 publication Critical patent/DE60020444T2/de

2020-04-07 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DE60020444T 1999-04-08 2000-04-06 Melanoma Therapie Expired - Lifetime DE60020444T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28836699A	1999-04-08	1999-04-08
US288366		1999-04-08

Publications (2)

Publication Number	Publication Date
DE60020444D1 true DE60020444D1 (de)	2005-07-07
DE60020444T2 DE60020444T2 (de)	2006-05-04

Family

ID=23106795

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE60020444T Expired - Lifetime DE60020444T2 (de)	1999-04-08	2000-04-06	Melanoma Therapie
DE60041290T Expired - Lifetime DE60041290D1 (de)	1999-04-08	2000-04-06	Melanoma Therapie
DE60045591T Expired - Lifetime DE60045591D1 (de)	1999-04-08	2000-04-06	Melanomtherapie

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DE60041290T Expired - Lifetime DE60041290D1 (de)	1999-04-08	2000-04-06	Melanoma Therapie
DE60045591T Expired - Lifetime DE60045591D1 (de)	1999-04-08	2000-04-06	Melanomtherapie

Country Status (22)

Country	Link
EP (3)	EP1535622B1 (de)
JP (1)	JP2000319195A (de)
CN (1)	CN1390132A (de)
AR (1)	AR023398A1 (de)
AT (3)	ATE496631T1 (de)
AU (1)	AU771569B2 (de)
BR (1)	BR0009646A (de)
CA (1)	CA2303992A1 (de)
CO (1)	CO5170404A1 (de)
CY (1)	CY1108922T1 (de)
DE (3)	DE60020444T2 (de)
DK (2)	DK1043026T3 (de)
ES (2)	ES2319776T3 (de)
HK (2)	HK1032349A1 (de)
HU (1)	HU230057B1 (de)
MY (1)	MY126763A (de)
NO (1)	NO328111B1 (de)
PE (1)	PE20010027A1 (de)
PT (2)	PT1043026E (de)
TW (1)	TWI292320B (de)
WO (1)	WO2000061175A2 (de)
ZA (1)	ZA200108173B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2828940C (en)	2011-03-10	2024-04-16	Provectus Pharmaceuticals, Inc.	Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4530901A (en)	1980-01-08	1985-07-23	Biogen N.V.	Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US6936694B1 (en)	1982-05-06	2005-08-30	Intermune, Inc.	Manufacture and expression of large structural genes
US4492537A (en)	1982-12-10	1985-01-08	Awerkamp John B	Fluid-operated oil or water well pump
US4766106A (en)	1985-06-26	1988-08-23	Cetus Corporation	Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en)	1985-06-26	1990-04-17	Cetus Corporation	Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
JP2514950B2 (ja)	1986-03-10	1996-07-10	エフ・ホフマン―ラロシユアーゲー	化学修飾蛋白質，その製造法および中間体
US5595732A (en)	1991-03-25	1997-01-21	Hoffmann-La Roche Inc.	Polyethylene-protein conjugates
US5382657A (en)	1992-08-26	1995-01-17	Hoffmann-La Roche Inc.	Peg-interferon conjugates
PT730470E (pt)	1993-11-10	2002-08-30	Enzon Inc	Conjugados melhorados de interferao-polimero
US5766582A (en)	1994-10-11	1998-06-16	Schering Corporation	Stable, aqueous alfa interferon solution formulations
JP2758154B2 (ja)	1995-04-06	1998-05-28	エフ・ホフマン−ラロシユアーゲー	インターフェロンを含む液体製剤
US5908621A (en) *	1995-11-02	1999-06-01	Schering Corporation	Polyethylene glycol modified interferon therapy
TW517067B (en)	1996-05-31	2003-01-11	Hoffmann La Roche	Interferon conjugates

2000
- 2000-04-06 EP EP05002951A patent/EP1535622B1/de not_active Expired - Lifetime
- 2000-04-06 ES ES05002951T patent/ES2319776T3/es not_active Expired - Lifetime
- 2000-04-06 WO PCT/US2000/009129 patent/WO2000061175A2/en active Application Filing
- 2000-04-06 CA CA002303992A patent/CA2303992A1/en not_active Abandoned
- 2000-04-06 PT PT00107101T patent/PT1043026E/pt unknown
- 2000-04-06 DK DK00107101T patent/DK1043026T3/da active
- 2000-04-06 CN CN00808452A patent/CN1390132A/zh active Pending
- 2000-04-06 AT AT08020311T patent/ATE496631T1/de not_active IP Right Cessation
- 2000-04-06 AR ARP000101574A patent/AR023398A1/es unknown
- 2000-04-06 AU AU42046/00A patent/AU771569B2/en not_active Ceased
- 2000-04-06 CO CO00025236A patent/CO5170404A1/es not_active Application Discontinuation
- 2000-04-06 EP EP00107101A patent/EP1043026B1/de not_active Expired - Lifetime
- 2000-04-06 TW TW089106309A patent/TWI292320B/zh not_active IP Right Cessation
- 2000-04-06 PT PT05002951T patent/PT1535622E/pt unknown
- 2000-04-06 DE DE60020444T patent/DE60020444T2/de not_active Expired - Lifetime
- 2000-04-06 AT AT05002951T patent/ATE419001T1/de active
- 2000-04-06 AT AT00107101T patent/ATE296639T1/de active
- 2000-04-06 ES ES00107101T patent/ES2239954T3/es not_active Expired - Lifetime
- 2000-04-06 PE PE2000000310A patent/PE20010027A1/es not_active Application Discontinuation
- 2000-04-06 DE DE60041290T patent/DE60041290D1/de not_active Expired - Lifetime
- 2000-04-06 JP JP2000105524A patent/JP2000319195A/ja not_active Withdrawn
- 2000-04-06 DE DE60045591T patent/DE60045591D1/de not_active Expired - Lifetime
- 2000-04-06 DK DK05002951T patent/DK1535622T3/da active
- 2000-04-06 BR BR0009646-6A patent/BR0009646A/pt not_active Application Discontinuation
- 2000-04-06 HU HU0200775A patent/HU230057B1/hu not_active IP Right Cessation
- 2000-04-06 EP EP08020311A patent/EP2025344B1/de not_active Expired - Lifetime
- 2000-04-07 MY MYPI20001454A patent/MY126763A/en unknown
2001
- 2001-03-26 HK HK01102202A patent/HK1032349A1/xx not_active IP Right Cessation
- 2001-10-04 ZA ZA200108173A patent/ZA200108173B/en unknown
- 2001-10-05 NO NO20014852A patent/NO328111B1/no not_active IP Right Cessation
2005
- 2005-11-02 HK HK05109748.1A patent/HK1075416A1/xx not_active IP Right Cessation
2009
- 2009-03-24 CY CY20091100351T patent/CY1108922T1/el unknown

Also Published As

Publication number	Publication date
DE60041290D1 (de)	2009-02-12
ATE419001T1 (de)	2009-01-15
HU230057B1 (hu)	2015-06-29
ES2319776T3 (es)	2009-05-12
ZA200108173B (en)	2003-01-06
EP1535622A1 (de)	2005-06-01
ATE496631T1 (de)	2011-02-15
AU771569B2 (en)	2004-03-25
TWI292320B (en)	2008-01-11
WO2000061175A2 (en)	2000-10-19
CO5170404A1 (es)	2002-06-27
DK1043026T3 (da)	2005-07-04
EP2025344A1 (de)	2009-02-18
CN1390132A (zh)	2003-01-08
ATE296639T1 (de)	2005-06-15
AR023398A1 (es)	2002-09-04
EP2025344B1 (de)	2011-01-26
EP1043026A3 (de)	2000-12-20
ES2239954T3 (es)	2005-10-16
MY126763A (en)	2006-10-31
DK1535622T3 (da)	2009-04-20
DE60020444T2 (de)	2006-05-04
DE60045591D1 (de)	2011-03-10
WO2000061175A3 (en)	2001-02-01
EP1043026A2 (de)	2000-10-11
HK1075416A1 (en)	2005-12-16
NO20014852D0 (no)	2001-10-05
JP2000319195A (ja)	2000-11-21
NO20014852L (no)	2001-12-06
NO328111B1 (no)	2009-12-07
CA2303992A1 (en)	2000-10-08
HK1032349A1 (en)	2001-07-20
PT1043026E (pt)	2005-09-30
HUP0200775A3 (en)	2002-09-30
CY1108922T1 (el)	2014-07-02
PE20010027A1 (es)	2001-02-05
HUP0200775A2 (en)	2002-08-28
EP1043026B1 (de)	2005-06-01
EP1535622B1 (de)	2008-12-31
AU4204600A (en)	2000-11-14
PT1535622E (pt)	2009-03-19
BR0009646A (pt)	2002-02-05

Publication	Publication Date	Title
DK1637127T3 (da)	2014-08-04	Terapeutisk mikroskum
NO20021400D0 (no)	2002-03-20	Terapeutiske konazolinderivater
DE69924365D1 (de)	2005-04-28	Massagegerät
ID27841A (id)	2001-04-26	Turunan-turunan biaril terapeutik
PT1060695E (pt)	2005-01-31	Cadeira empilhavel
PT1235558E (pt)	2006-09-29	Agentes terapeuticos
NO20014490L (no)	2001-11-14	Medisinske blandinger
DE60017816D1 (de)	2005-03-10	Herzschrittmacher
ATE284637T1 (de)	2005-01-15	Matratze
DE60016600D1 (de)	2005-01-13	Herzschrittmacher
DE59911113D1 (de)	2004-12-23	Herzschrittmacher
ITMI991895A0 (it)	1999-09-09	Depigmentanti cutanei
DE69916133D1 (de)	2004-05-06	Elektro-neuro-adaptiver stimulator
PT1178981E (pt)	2003-11-28	3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE60013608D1 (de)	2004-10-14	Herzschrittmacher
DE50010867D1 (de)	2005-09-08	Abdeckvorrichtung
NO20016301D0 (no)	2001-12-21	Terapeutiske midler
DE60016452D1 (de)	2005-01-05	Herzschrittmacher
FR2800592B3 (fr)	2001-10-19	Matelas
ATE296639T1 (de)	2005-06-15	Melanoma therapie
FI19992468L (fi)	2001-05-18	Tuoli
DE50005638D1 (de)	2004-04-22	Abdeckvorrichtung
FI4027U1 (fi)	1999-07-05	Tuoli
SE9900567D0 (sv)	1999-02-19	Avskjutningsramp
ES1044621Y (es)	2000-10-16	Tumbona perfeccionada

Legal Events

Date	Code	Title	Description
2006-06-29	8364	No opposition during term of opposition